Sofya A. Tsarkova

Sofya A. Tsarkova

Auto-generated profile, based on publicly available information

Sofya A. Tsarkova

Ural State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2021 in Current Pediatrics
Verified
Journal Article
Open access
PDF file
YYYakov Y. Yakovlev
Yakov Y. Yakovlev
FMFarok K. Manerov
Farok K. Manerov
VFVladimir I. Furtsev
Vladimir I. Furtsev
VSVladimir A. Shcherbak
Vladimir A. Shcherbak
NSNatalya M. Shcherbak
Natalya M. Shcherbak
ЯМЯ. А. Мунхалова
Я. А. Мунхалова
Background. The ratio of breasted children for more than six months increased from 33 to 40% in the period from 1991 to 2019 according to the Russian Federal State Statistics Service. This number has not changed in recent 12 years and remained on the level of 39-41%. Relatively low adherence to breastfeeding may be the consequence of the lack of training of future doctors in these issues.Objective. The aim of the study was to analyse the knowledge (and its dynamics over the past decade) of medical students, interns and residents on breastfeeding support and promotion in Russian Federation.Methods. We have conducted the survey among senior students, interns, and residents in 2009-2011 and 2018-2019. 8 medical universities participated in the study in 2009-2011, and 24 medical universities and one continuing education institute — in 2018-2019. Knowledge on breastfeeding support issues was estimated according to the results of future doctors’ responses to the proposed questionnaires.Results. Sample of 2009-2011 has included 1088 students, interns, and residents, sample of 2018-2019 — 3694. There is still high level of mistakes in the breastfeedng issues due to the decline in knowledge of the WHO breastfeeding recommendations. The level of understanding of practical aspects has not changed significantly over the 10 years, and there is still a gap between theoretical knowledge and practice.Conclusion. The necessity to improve quality of future doctors training in breastfeeding issues is shown.

8 June 2024 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
STSofya A. Tsarkova
Sofya A. Tsarkova
OZOlga V. Zaytseva
Olga V. Zaytseva
ELEvelina Lokshina
Evelina Lokshina
SZSvetlana V. Zaytseva
Svetlana V. Zaytseva
EIElena P. Isaeva
Elena P. Isaeva
ХЮХалидуллина Оксана Юрьевна
Халидуллина Оксана Юрьевна
Background. Currently, there are no multicenter studies to determine the prevalence and incidence of symptoms of post-COVID syndrome (PCS) in children in different age groups, to develop consistent observation algorithms, and to identify therapy options. Aim. To establish the risk factors for PCS in children and its CSs in the Russian Federation. Materials and methods. A retrospective multicenter cross-sectional study was conducted. The initial stage of the study included 565 children at 7.6±0.17 months after the new coronavirus infection (NCVI) who were on outpatient or inpatient observation in different regions of Russia from November 2022 to May 2023. Patients were selected from 9 regions of the Russian Federation, such as Izhevsk, Kemerovo, Moscow, Omsk and Omsk region, Yekaterinburg and Sverdlovsk region, Ufa, Tyumen, Samara, Naberezhnye Chelny. All patients were offered a questionnaire. The questionnaire was developed and adapted based on the British and American consensus on the PCS, which included an assessment of the history, severity of the disease, clinical form of acute NCVI, therapy in the acute period of NCVI, and the presence of comorbidities. In addition, the course of acute NCVI and symptoms 3 months after the disease were evaluated by the following groups of CS: asthenia, respiratory disorders (RD), gastrointestinal disorders (GI), neurocognitive disorders (NCD), skin/adnexal lesions, olfactory/taste disorders, autonomic dysfunction (AD), anxiety. Of the 565 questionnaires received, 435 (76.9%) met the inclusion criteria and were available for subsequent analysis. The mean age was 9.0±0.25 years. Results. During the acute period of the NCVI, asthenic syndrome (AS), RD and NCD, anxiety symptoms, olfactory/taste disorders, manifestations of AD, GI and skin/adnexal lesions were most often detected. Our study showed that after 3 months or more after NKVI, AS, NCD, and RD recurred in almost half of the observed children (53.1, 49.0 and 47.8%, respectively), anxiety was detected in 42,5% of cases, in more than 1/5 of children, AD, olfactory/taste and gastrointestinal disorders, in 14.3% skin/appendage lesions. Even 90 days after recovery from NCVI, more than half of patients reported impaired functionality, and most children had multiple complaints, which significantly impaired their quality of life. The risk of developing certain manifestations of PCS was increased in patients with comorbidities. Conclusion. The study found that PCS developed in patients with severe, moderate, and mild acute COVID-19. The presence of comorbidities (allergic, neurological diseases, ENT disorders) statistically significantly increased the risk of PCS. The study's results further confirm the importance of continuous monitoring of NKVI sequelae in children and adolescents and the need for follow-up in children recovered from NKVI for 3-12 months.

22 September 2020 in Therapy
Verified
Journal Article
Closed access
VVVavilova V.P. Vavilova
Vavilova V.P. Vavilova
VVVavilov A.M. Vavilov
Vavilov A.M. Vavilov
PPPerevochikova N.K. Perevochikova
Perevochikova N.K. Perevochikova
TTTsarkova S.A. Tsarkova
Tsarkova S.A. Tsarkova
PPPivovar O.I. Pivovar
Pivovar O.I. Pivovar
NRNovokuznetsk State Institute of Advanced Medical Studies – branch of Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia
Novokuznetsk State Institute of Advanced Medical Studies – branch of Russian Medical Academy of Continuing Professional Education of the Ministry of Healthcare of Russia

18 January 2023 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
VVVera P. Vavilova
Vera P. Vavilova
AVAlexander M. Vavilov
Alexander M. Vavilov
STSofya A. Tsarkova
Sofya A. Tsarkova
ONOlga L. Nesterova
Olga L. Nesterova
AKAleksandra A. Kulyabina
Aleksandra A. Kulyabina
ДАДобряк Татьяна Александровна
Добряк Татьяна Александровна
Background. The issue of acute respiratory infections in children remains one of the most urgent. Therefore, in the pandemic due to the new coronavirus SARS-CoV-2, the search for effective treatment regimens for this disease is necessary. Aim. To compare the change of clinical symptoms, terms of virus elimination and disease-related economic cost as well as utilization of outpatient healthcare services in children with new coronavirus infection using the herbal medicine Tonsilgon N, oral solution, added to standard therapy. Materials and methods. A prospective open comparative cohort study of the effectiveness of coronavirus infection treatment in children using the standard of care alone and the standard of care with Tonsilgon N was conducted. Group 1 children (n=720) received the standard therapy for COVID-19 and Tonsilgon N oral solution for 10 days, and group 2 patients (n=670) only received the standard therapy for COVID-19. Treatment efficacy was evaluated according to the change of clinical symptoms in the observed patients, the results of SARS-CoV-2 coronavirus RNA detection in nasopharyngeal smears by polymerase chain reaction, the utilization of healthcare services, temporary disability of parents, the economic cost of the disease. Results. Studied patients of both groups had a typical clinical presentation of mild to moderate severity new coronavirus infection. Fatigue (96.599.7%) and sore throat (93.893.9%) were the most frequent symptoms. Posterior pharynx hyperemia was noted slightly less frequently. Low-grade fever was noted in 85.786.6% of the patients, equally often in patients of both groups. The significant therapeutic effect of the herbal medicine containing extract of marshmallow root, chamomile flowers, horsetail herb, walnut leaf, yarrow herb, oak bark, and dandelion herb includes reducing the time of sore throat relief in 93.2% of main group patients. After 10 days of treatment, sore throat persisted only in 6.8% of group 1 and 68.1% of group 2 patients (p=0.0001). These results indicate that Tonsilgon combined with standard of care is a promising way to improve the quality of life of children with the new coronavirus infection. The addition of Tonsilgon in therapy for new coronavirus infection in children shortens the time of acute inflammation resolution and reduces the duration of inflammatory intoxication. The therapy of new coronavirus infection under the provisional guidelines leads to a reduction in the time for clinical recovery and virus elimination in children and adolescents (p=0.0001) and a decrease in the utilization of outpatient healthcare services are observed: 3/4 of Group 1 patients and 1/2 of Group 2 patients (p=0.0001) applied for medical help twice during the observation period, 14.6% of Group 1 patients and 29.1% of Group 2 parents applied for medical help more than 3 times (p=0.0001). Thus, the direct and indirect economic costs of the disease decreased. The lower economic cost for parents of children in Group 1 was due to less need for medication and a lower reduction in family income due to temporary disability compared to those for parents in Group 2 (p=0.0001). No treatment-related adverse events was reported. Conclusion. The above data indicate that Tonsilgon therapy is an affordable way to optimize the treatment of new coronavirus infection in children.

1 January 2020 in Doctor.Ru
Verified
Journal Article
Open access
UFUral State Medical University of the Ministry of Health of the Russian Federation
Ural State Medical University of the Ministry of Health of the Russian Federation
STS.A. Tsarkova
S.A. Tsarkova
RERussian Federation Ekaterinburg
Russian Federation Ekaterinburg
RUR.A. Ushakova
R.A. Ushakova
NGN.E. Gromada
N.E. Gromada
OMO.R. Musalova
O.R. Musalova
Objective of the Paper: To present a case study of progressive Duchenne – Becker muscular dystrophy (PMD) and demonstrate challenges and features of diagnosis of this pathology. Key Points. The article discusses a case of Duchenne – Becker PMD diagnosis in a 2-year old boy. We have described stages of diagnostic investigation and analysed the results of clinical observation and molecular genetic examination. We have proposed an examination algorithm for unexplained increase in aspartate aminotransferase (AAT), alanine aminotransferase (ALT) activity. Conclusion. This case of PMD demonstrates challenges faced by health care providers in diagnosis of this condition. Early clinical symptoms, increased blood AAT and ALT, creatine phosphokinase are a reason for a molecular genetic examination. This algorithm can be used to diagnose PMD in order to save efforts searching for a non-existent neurological pathology and infection, promptly prescribe an adequate therapy and improve the quality of patient’s life. Keywords: progressive Duchenne – Becker muscular dystrophy, molecular genetic examination, aspartate aminotransferase, alanine aminotransferase, creatine phosphokinase.

1 January 2021 in Doctor.Ru
Verified
Journal Article
Open access
NGNatalia Geppe
Natalia Geppe
NKN.G. Kolosova
N.G. Kolosova
AMA.B. Malakhov
A.B. Malakhov
VEVelikoretskaya
Velikoretskaya
TKT.N. Kozhevnikova
T.N. Kozhevnikova
RMRussian Federation Murom District Children Hospital; Murom
Russian Federation Murom District Children Hospital; Murom
Study Objective: To obtain additional information on efficacy and safety of the use of a fixed combination of Paracetamol and Ibuprofen in children with fever associated with acute respiratory tract infection (ARTI). Study Design: Multicentre open-label cohort observational study. Materials and Methods. 242 children aged 3 to 12 years old (mean age: 6.3 ± 2.7 years old) with ARTI and fever participated in the study. When the body temperature was 38.1°С and higher, we used an antipyretic combination: a dispersible tablet containing 100mg Ibuprofen and 125mg Paracetamol (Ibuclin Junior®), 1 tablet 3 times daily in children aged 3 to 6 years old, and up to 6 tablets in children aged 7 to 12 years old (max. for 4 days). We evaluated the clinical efficacy and safety of the antipyretic therapy, parents’ satisfaction (using the Integrative Medicine Patient Satisfaction Scale), and quality of child’s life (sleep, appetite, play activity). Study Results. During examination, mean body temperature was 38.8°С (mostly 38.6 to 39.0°С). On day 1, 2, 3, and 4, antipyretic therapy was needed by 242 (100%), 168 (69.4%), 65 (26.9%), and 2 (0.8%) children, respectively. During first two days, patients took on an average 2 tablets, then 1 tablet. After the first dose, the normal body temperature (< 37.2°C) in 1, 4, 24, 48, and 72 hours was observed in 14%, 62%, 43.4%, 71.5%, and 98% of patients; while the mean body temperature was 37.6; 37.1; 37.6; 37.0, and 36.5°С, respectively. No adverse events or therapy failures were recorded during the study. In 48 and 72 hours after initiation of therapy, a share of parents who were “completely satisfied” and “satisfied” with the medicinal product was 86,4% and 95,9%, respectively. Poor quality of child’s life correlated with severity of fever; in 96 hours after therapy initiation, sleep and play activity normalised in over 90% of patients, appetite got better in 77%. Conclusion. Study results demonstrate high efficacy (even after the first dose) and safety of a combination product (dispersible tablets containing Ibuprofen and Paracetamol) for the management of fever in children with ARTI; and the product can be recommended for wide use in paediatrics. Keywords: children, acute respiratory tract infections, fever, Paracetamol, Ibuprofen.